This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ceres Announces Financial Results For Fiscal Year 2012

Cost of product sales was $0.5 million for the quarter ended August 31, 2012 compared to $0.6 million for the quarter ended August 31, 2011.

Research and development expenses were $3.6 million for the quarter ended August 31, 2012 compared to $5.2 million for the quarter ended August 31, 2011.

Selling, general and administrative expenses were $3.7 million for the quarter ended August 31, 2012 compared to $3.1 million for the quarter ended August 31, 2011.

For the quarter ended August 31, 2012, Ceres reported a net loss of $6.6 million, or $0.27 per share, compared to a net loss of $16.8 million, or $8.34 per share, for the quarter ended August 31, 2011.

YEAR-END FINANCIAL RESULTS

Total revenues for the year ended August 31, 2012 were $5.4 million compared to $6.6 million for the prior fiscal year. The decrease was driven primarily by decreased activity under collaborative research and government grants. The decrease was partially offset by an increase in product sales in Brazil.

Cost of product sales was $2.4 million for the year ended August 31, 2012 compared to $2.5 million for the previous fiscal year. The decrease was primarily due to reduced seed production of certain products targeting the U.S. biomass-to-bioenergy markets. This decrease was mostly offset by increased costs in Brazil related to increased sweet sorghum seed sales.

Research and development expenses increased by $0.1 million to $19.2 million for the year ended August 31, 2012 compared to the previous fiscal year. This increase is partially attributable to increased R&D expenses in Brazil of $1.7 million relating to additional personnel and costs associated with the company’s Brazil sorghum breeding and agronomy operations. The remaining increase is attributable to an increase in personnel and other related overhead expenses in the U.S. of $0.6 million. These cost increases were offset by reduced non-cash expenses related to warrants issued in connection with our collaborations of $1.8 million and reduced costs in consulting, licensing and external research and development of $0.4 million.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,997.93 -37.00 -0.21%
S&P 500 2,103.76 +3.36 0.16%
NASDAQ 5,018.0050 +23.4030 0.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs